122 related articles for article (PubMed ID: 12729997)
1. Mutation prevention concentration of ceftriaxone, meropenem, imipenem, and ertapenem against three strains of Streptococcus pneumoniae.
Hovde LB; Rotschafer SE; Ibrahim KH; Gunderson B; Hermsen ED; Rotschafer JC
Diagn Microbiol Infect Dis; 2003 Apr; 45(4):265-7. PubMed ID: 12729997
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamic modeling of carbapenems and fluoroquinolones against bacteria that produce extended-spectrum beta-lactamases.
Moczygemba LR; Frei CR; Burgess DS
Clin Ther; 2004 Nov; 26(11):1800-7. PubMed ID: 15639692
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of ertapenem (MK-0826) against multi-drug resistant Streptococcus pneumoniae compared with 13 other antimicrobials.
Hilliard NJ; Johnson CN; Armstrong SH; Quarles S; Waites KB
Int J Antimicrob Agents; 2002 Aug; 20(2):136-40. PubMed ID: 12297363
[TBL] [Abstract][Full Text] [Related]
4. In vitro antianaerobic activity of ertapenem (MK-0826) compared to seven other compounds.
Hoellman DB; Kelly LM; Credito K; Anthony L; Ednie LM; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2002 Jan; 46(1):220-4. PubMed ID: 11751138
[TBL] [Abstract][Full Text] [Related]
5. Comparative in vitro killing activities of meropenem, imipenem, ceftriaxone, and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolates from children with meningitis.
Fitoussi F; Doit C; Benali K; Bonacorsi S; Geslin P; Bingen E
Antimicrob Agents Chemother; 1998 Apr; 42(4):942-4. PubMed ID: 9559815
[TBL] [Abstract][Full Text] [Related]
6. Comparison of in vitro efficacy of ertapenem, imipenem and meropenem in the infections caused by the Enterobacteriaceae strains family.
Guzek A; Tomaszewski D; Rybicki Z; Truszczyński A; Barański M; Korzeniewski K
Anaesthesiol Intensive Ther; 2013; 45(2):67-72. PubMed ID: 23877897
[TBL] [Abstract][Full Text] [Related]
7. [In vitro emergence of ertapenem resistance in Escherichia coli producing extended-spectrum β-lactamase].
Villar HE; Jugo MB; Visser M; Hidalgo M; Hidalgo G; Maccallini GC
Rev Esp Quimioter; 2014 Mar; 27(1):51-5. PubMed ID: 24676243
[TBL] [Abstract][Full Text] [Related]
8. Use of surrogate antimicrobial agents to predict susceptibility to ertapenem.
Friedland IR; Isaacs R; Mixson LA; Motyl M; Woods GL
Diagn Microbiol Infect Dis; 2002 May; 43(1):61-4. PubMed ID: 12052630
[TBL] [Abstract][Full Text] [Related]
9. [Investigation of the susceptibilities of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. strains to ertapenem and other carbapenems].
Kuzucu C; Yetkin F; Görgeç S; Ersoy Y
Mikrobiyol Bul; 2011 Jan; 45(1):28-35. PubMed ID: 21341156
[TBL] [Abstract][Full Text] [Related]
10. Effect of High N-Acetylcysteine Concentrations on Antibiotic Activity against a Large Collection of Respiratory Pathogens.
Landini G; Di Maggio T; Sergio F; Docquier JD; Rossolini GM; Pallecchi L
Antimicrob Agents Chemother; 2016 Dec; 60(12):7513-7517. PubMed ID: 27736757
[TBL] [Abstract][Full Text] [Related]
11. In vitro antibacterial activities of doripenem, imipenem, and meropenem against recent Streptococcus pneumoniae isolates.
Baek JY; Ko KS; Kang CI; Song JH; Peck KR
Diagn Microbiol Infect Dis; 2011 Nov; 71(3):297-300. PubMed ID: 21855246
[TBL] [Abstract][Full Text] [Related]
12. Activity of three {beta}-lactams (ertapenem, meropenem and ampicillin) against intraphagocytic Listeria monocytogenes and Staphylococcus aureus.
Lemaire S; Van Bambeke F; Mingeot-Leclercq MP; Tulkens PM
J Antimicrob Chemother; 2005 Jun; 55(6):897-904. PubMed ID: 15860552
[TBL] [Abstract][Full Text] [Related]
13. Use of Carbapenems against clinical, nontyphoid Salmonella isolates: results from in vitro and in vivo animal studies.
Tang HJ; Chen CC; Zhang CC; Cheng KC; Chiang SR; Chiu YH; Ku YH; Ko WC; Chuang YC
Antimicrob Agents Chemother; 2012 Jun; 56(6):2916-22. PubMed ID: 22470122
[TBL] [Abstract][Full Text] [Related]
14. Comparison of disk diffusion, Etest and VITEK2 for detection of carbapenemase-producing Klebsiella pneumoniae with the EUCAST and CLSI breakpoint systems.
Vading M; Samuelsen Ø; Haldorsen B; Sundsfjord AS; Giske CG
Clin Microbiol Infect; 2011 May; 17(5):668-74. PubMed ID: 20649801
[TBL] [Abstract][Full Text] [Related]
15. In Vitro Comparison of Ertapenem, Meropenem, and Imipenem against Isolates of Rapidly Growing Mycobacteria and Nocardia by Use of Broth Microdilution and Etest.
Brown-Elliott BA; Killingley J; Vasireddy S; Bridge L; Wallace RJ
J Clin Microbiol; 2016 Jun; 54(6):1586-1592. PubMed ID: 27053677
[TBL] [Abstract][Full Text] [Related]
16. [Investigation of the in-vitro effectiveness of ertapenem against Pseudomonas aeruginosa strains isolated from intensive care unit patients].
Kiliç A; Küçükkaraaslan A; Senses Z; Baysallar M; Doğanci L
Mikrobiyol Bul; 2004 Oct; 38(4):355-62. PubMed ID: 15700661
[TBL] [Abstract][Full Text] [Related]
17. Bactericidal activities of meropenem and ertapenem against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a neutropenic mouse thigh model.
DeRyke CA; Banevicius MA; Fan HW; Nicolau DP
Antimicrob Agents Chemother; 2007 Apr; 51(4):1481-6. PubMed ID: 17283197
[TBL] [Abstract][Full Text] [Related]
18. Decreased susceptibility to imipenem among penicillin-resistant Streptococcus pneumoniae.
Pikis A; Donkersloot JA; Akram S; Keith JM; Campos JM; Rodriguez WJ
J Antimicrob Chemother; 1997 Jul; 40(1):105-8. PubMed ID: 9249211
[TBL] [Abstract][Full Text] [Related]
19. Effect of β-lactamase production and β-lactam instability on MIC testing results for Mycobacterium abscessus.
Rominski A; Schulthess B; Müller DM; Keller PM; Sander P
J Antimicrob Chemother; 2017 Nov; 72(11):3070-3078. PubMed ID: 28961987
[TBL] [Abstract][Full Text] [Related]
20. Carbapenem susceptibility among Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae isolates obtained from patients in intensive care units in Taiwan in 2005, 2007, and 2009.
Jean SS; Lee WS; Bai KJ; Yu KW; Hsu CW; Yu KW; Liao CH; Chang FY; Ko WC; Wu JJ; Chen YH; Chen YS; Liu JW; Lu MC; Liu CY; Chen RJ; Hsueh PR
Diagn Microbiol Infect Dis; 2015 Apr; 81(4):290-5. PubMed ID: 25600841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
